CAM
CLLS

Cresset Asset Management’s Cellectis CLLS Stock Holding History

Cresset Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,407
Closed -$336K – 939
2020
Q4 		$336K Buy
12,407
+2,251
+22% +$50.5K 0.01% 524
2020
Q3 		$188K Buy
+10,156
New +$180K ﹤0.01% 655

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

Cresset Asset Management's CLLS Position: Q1 2021 in Review

Cresset Asset Management sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 12,407 shares — an estimated $336K sold.

Cresset Asset Management first reported a position in CLLS in Q3 2020 and held it in 2 quarters. The position peaked at $336K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Cresset Asset Management reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Cresset Asset Management sold 12,407 Cellectis shares in Q1 2021, an estimated $336K.
  • Cresset Asset Management first reported a position in Cellectis in Q3 2020 and held it in 2 quarters.
  • Cresset Asset Management's Cellectis position peaked at $336K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Cresset Asset Management's 13F filing for Q1 2021, filed 12 May 2021.